Get the Stockscreener App
6.46
0.15%
-0.010
After Hours:
6.36
-0.10
-1.55%
Glucotrack Inc stock is traded at $6.46, with a volume of 38,477.
It is down -0.15% in the last 24 hours and down -12.70% over the past month.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
See More
Previous Close:
$6.47
Open:
$6.42
24h Volume:
38,477
Relative Volume:
0.03
Market Cap:
$5.81M
Revenue:
-
Net Income/Loss:
$-26.77M
P/E Ratio:
-0.00491
EPS:
-1316.2474
Net Cash Flow:
$-14.37M
1W Performance:
-2.71%
1M Performance:
-12.70%
6M Performance:
+3,729%
1Y Performance:
-81.44%
1-Day Range:
$6.2905
$6.47
1-Week Range:
$6.2905
$7.4999
52-Week Range:
$0.0927
$48.80
Glucotrack Inc Stock (GCTK) Company Profile
Name
Glucotrack Inc
Sector
Industry
Phone
972 (8) 675-7878
Address
301 RT 17 NORTH, RUTHERFORD
Compare GCTK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
6.46 | 5.89M | 0 | -26.77M | -14.37M | -1,316.25 |
|
ISRG
Intuitive Surgical Inc
|
544.21 | 189.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
177.30 | 51.22B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
73.88 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
248.95 | 36.04B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
279.78 | 20.29B | 2.96B | 487.70M | 344.00M | 6.6758 |
Glucotrack Inc Stock (GCTK) Latest News
Glucotrack, Inc. Encourages Shareholders to Vote on Equity Purchase Agreement - TradingView
Glucotrack, Inc. Encourages Shareholders to Vote - The Manila Times
How GlucoTrack Inc. stock reacts to bond yieldsPortfolio Profit Report & Weekly Hot Stock Watchlists - newser.com
Key resistance and support levels for GlucoTrack Inc.July 2025 Levels & Real-Time Stock Movement Alerts - newser.com
Does GlucoTrack Inc. stock trade at a discount to peers2025 Major Catalysts & Real-Time Stock Entry Alerts - newser.com
GlucoTrack Inc. stock daily chart insightsQuarterly Market Review & Smart Allocation Stock Tips - newser.com
Technical analysis overview for GlucoTrack Inc. stock2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com
How GlucoTrack Inc. stock reacts to job market dataBond Market & AI Forecasted Entry and Exit Points - newser.com
Can machine learning forecast GlucoTrack Inc. recoveryJuly 2025 Trends & Target Return Focused Stock Picks - newser.com
How interest rate cuts could boost GlucoTrack Inc. stockJuly 2025 Decliners & Weekly High Potential Stock Alerts - newser.com
GlucoTrack Inc trading resumes - MSN
GCTK registers 20,060,000 shares for Sixth Borough resale - Stock Titan
What drives GlucoTrack Inc stock priceIPO Market Watch & Build Wealth With Zero-Cost Tools - earlytimes.in
GlucoTrack Inc trading halted, volatility trading pause - MSN
Glucotrack’s Innovative Glucose Sensor Study: A Potential Game-Changer for Diabetes Management - MSN
GlucoTrack Appoints Dr. Usman Latif to Advisory Team - TipRanks
Glucotrack, Inc. Appoints Usman Latif to Clinical Advisory Team - TradingView
[8-K] Glucotrack, Inc. Reports Material Event | GCTK SEC FilingForm 8-K - Stock Titan
Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team - The Manila Times
Glucotrack (NASDAQ: GCTK) taps Dr. Usman Latif to guide epidural glucose monitoring - Stock Titan
GlucoTrack Announces Special Shareholder Meeting for Equity Vote - TipRanks
Glucotrack, Inc. Announces Special Shareholder Meeting - TradingView
GCTK files 8-K; Regulation FD press release furnished (Ex. 99.1) - Stock Titan
Glucotrack, Inc. Reminds Shareholders to Vote - The Manila Times
How to read the order book for GlucoTrack Inc.July 2025 Levels & Risk Controlled Daily Plans - newser.com
Glucotrack (NASDAQ: GCTK) sets Oct 31 special meeting on Equity Purchase Agreement - Stock Titan
Glucotrack Inc Stock (GCTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.41%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):